4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001179110-11-010954
Executive VP, CMO acquired 50,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Youssoufian Hagop Executive VP, CMO | 2011-07-15 | Grant or award | +50,000 | 50,000 | D | ||
| Derivatives | |||||||
| Youssoufian Hagop Executive VP, CMO | 2011-07-15 | Returned to the company · Stock Options (right to buy) | +250,000 | 250,000 | D | ||
Loading xslF345X03/edgar.xml…